Cargando…
Linking a dermal permeation and an inhalation model to a simple pharmacokinetic model to study airborne exposure to di(n-butyl) phthalate
Six males clad only in shorts were exposed to high levels of airborne di(n-butyl) phthalate (DnBP) and diethyl phthalate (DEP) in chamber experiments conducted in 2014. In two 6 h sessions, the subjects were exposed only dermally while breathing clean air from a hood, and both dermally and via inhal...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5658674/ https://www.ncbi.nlm.nih.gov/pubmed/27531370 http://dx.doi.org/10.1038/jes.2016.48 |
_version_ | 1783274054237552640 |
---|---|
author | Lorber, Matthew Weschler, Charles J Morrison, Glenn Bekö, Gabriel Gong, Mengyan Koch, Holger M Salthammer, Tunga Schripp, Tobias Toftum, Jørn Clausen, Geo |
author_facet | Lorber, Matthew Weschler, Charles J Morrison, Glenn Bekö, Gabriel Gong, Mengyan Koch, Holger M Salthammer, Tunga Schripp, Tobias Toftum, Jørn Clausen, Geo |
author_sort | Lorber, Matthew |
collection | PubMed |
description | Six males clad only in shorts were exposed to high levels of airborne di(n-butyl) phthalate (DnBP) and diethyl phthalate (DEP) in chamber experiments conducted in 2014. In two 6 h sessions, the subjects were exposed only dermally while breathing clean air from a hood, and both dermally and via inhalation when exposed without a hood. Full urine samples were taken before, during, and for 48 h after leaving the chamber and measured for key DnBP and DEP metabolites. The data clearly demonstrated high levels of DnBP and DEP metabolite excretions while in the chamber and during the first 24 h once leaving the chamber under both conditions. The data for DnBP were used in a modeling exercise linking dose models for inhalation and transdermal permeation with a simple pharmacokinetic model that predicted timing and mass of metabolite excretions. These models were developed and calibrated independent of these experiments. Tests included modeling of the “hood-on” (transdermal penetration only), “hood-off” (both inhalation and transdermal) scenarios, and a derived “inhalation-only” scenario. Results showed that the linked model tended to duplicate the pattern of excretion with regard to timing of peaks, decline of concentrations over time, and the ratio of DnBP metabolites. However, the transdermal model tended to overpredict penetration of DnBP such that predictions of metabolite excretions were between 1.1 and 4.5 times higher than the cumulative excretion of DnBP metabolites over the 54 h of the simulation. A similar overprediction was not seen for the “inhalation-only” simulations. Possible explanations and model refinements for these overpredictions are discussed. In a demonstration of the linked model designed to characterize general population exposures to typical airborne indoor concentrations of DnBP in the United States, it was estimated that up to one-quarter of total exposures could be due to inhalation and dermal uptake. |
format | Online Article Text |
id | pubmed-5658674 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-56586742017-10-30 Linking a dermal permeation and an inhalation model to a simple pharmacokinetic model to study airborne exposure to di(n-butyl) phthalate Lorber, Matthew Weschler, Charles J Morrison, Glenn Bekö, Gabriel Gong, Mengyan Koch, Holger M Salthammer, Tunga Schripp, Tobias Toftum, Jørn Clausen, Geo J Expo Sci Environ Epidemiol Original Article Six males clad only in shorts were exposed to high levels of airborne di(n-butyl) phthalate (DnBP) and diethyl phthalate (DEP) in chamber experiments conducted in 2014. In two 6 h sessions, the subjects were exposed only dermally while breathing clean air from a hood, and both dermally and via inhalation when exposed without a hood. Full urine samples were taken before, during, and for 48 h after leaving the chamber and measured for key DnBP and DEP metabolites. The data clearly demonstrated high levels of DnBP and DEP metabolite excretions while in the chamber and during the first 24 h once leaving the chamber under both conditions. The data for DnBP were used in a modeling exercise linking dose models for inhalation and transdermal permeation with a simple pharmacokinetic model that predicted timing and mass of metabolite excretions. These models were developed and calibrated independent of these experiments. Tests included modeling of the “hood-on” (transdermal penetration only), “hood-off” (both inhalation and transdermal) scenarios, and a derived “inhalation-only” scenario. Results showed that the linked model tended to duplicate the pattern of excretion with regard to timing of peaks, decline of concentrations over time, and the ratio of DnBP metabolites. However, the transdermal model tended to overpredict penetration of DnBP such that predictions of metabolite excretions were between 1.1 and 4.5 times higher than the cumulative excretion of DnBP metabolites over the 54 h of the simulation. A similar overprediction was not seen for the “inhalation-only” simulations. Possible explanations and model refinements for these overpredictions are discussed. In a demonstration of the linked model designed to characterize general population exposures to typical airborne indoor concentrations of DnBP in the United States, it was estimated that up to one-quarter of total exposures could be due to inhalation and dermal uptake. Nature Publishing Group 2017-11 2016-08-17 /pmc/articles/PMC5658674/ /pubmed/27531370 http://dx.doi.org/10.1038/jes.2016.48 Text en Copyright © 2017 Nature America, Inc., part of Springer Nature. http://creativecommons.org/licenses/by-nc-nd/4.0/ This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ |
spellingShingle | Original Article Lorber, Matthew Weschler, Charles J Morrison, Glenn Bekö, Gabriel Gong, Mengyan Koch, Holger M Salthammer, Tunga Schripp, Tobias Toftum, Jørn Clausen, Geo Linking a dermal permeation and an inhalation model to a simple pharmacokinetic model to study airborne exposure to di(n-butyl) phthalate |
title | Linking a dermal permeation and an inhalation model to a simple pharmacokinetic model to study airborne exposure to di(n-butyl) phthalate |
title_full | Linking a dermal permeation and an inhalation model to a simple pharmacokinetic model to study airborne exposure to di(n-butyl) phthalate |
title_fullStr | Linking a dermal permeation and an inhalation model to a simple pharmacokinetic model to study airborne exposure to di(n-butyl) phthalate |
title_full_unstemmed | Linking a dermal permeation and an inhalation model to a simple pharmacokinetic model to study airborne exposure to di(n-butyl) phthalate |
title_short | Linking a dermal permeation and an inhalation model to a simple pharmacokinetic model to study airborne exposure to di(n-butyl) phthalate |
title_sort | linking a dermal permeation and an inhalation model to a simple pharmacokinetic model to study airborne exposure to di(n-butyl) phthalate |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5658674/ https://www.ncbi.nlm.nih.gov/pubmed/27531370 http://dx.doi.org/10.1038/jes.2016.48 |
work_keys_str_mv | AT lorbermatthew linkingadermalpermeationandaninhalationmodeltoasimplepharmacokineticmodeltostudyairborneexposuretodinbutylphthalate AT weschlercharlesj linkingadermalpermeationandaninhalationmodeltoasimplepharmacokineticmodeltostudyairborneexposuretodinbutylphthalate AT morrisonglenn linkingadermalpermeationandaninhalationmodeltoasimplepharmacokineticmodeltostudyairborneexposuretodinbutylphthalate AT bekogabriel linkingadermalpermeationandaninhalationmodeltoasimplepharmacokineticmodeltostudyairborneexposuretodinbutylphthalate AT gongmengyan linkingadermalpermeationandaninhalationmodeltoasimplepharmacokineticmodeltostudyairborneexposuretodinbutylphthalate AT kochholgerm linkingadermalpermeationandaninhalationmodeltoasimplepharmacokineticmodeltostudyairborneexposuretodinbutylphthalate AT salthammertunga linkingadermalpermeationandaninhalationmodeltoasimplepharmacokineticmodeltostudyairborneexposuretodinbutylphthalate AT schripptobias linkingadermalpermeationandaninhalationmodeltoasimplepharmacokineticmodeltostudyairborneexposuretodinbutylphthalate AT toftumjørn linkingadermalpermeationandaninhalationmodeltoasimplepharmacokineticmodeltostudyairborneexposuretodinbutylphthalate AT clausengeo linkingadermalpermeationandaninhalationmodeltoasimplepharmacokineticmodeltostudyairborneexposuretodinbutylphthalate |